Neuromuscular disorders - Assessment of the respiratory muscles;Maladies neuromusculaires: Évaluation des fonctions ventilatoires

Revue Neurologique

Volumn 162, Issue 4, 2006, Pages 437-444

  Perez, T ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Arterial blood gases; Neuromuscular disease; Nocturnal oxymetry; Respiratory muscles; Spirometry

Indexed keywords

ARTERIAL GAS; BREATHING MUSCLE; CLINICAL FEATURE; COUGHING; DIAGNOSTIC APPROACH ROUTE; DYSPNEA; EVALUATION; HEADACHE; HUMAN; HYPOVENTILATION; LUNG CLEARANCE; LUNG FUNCTION TEST; MUSCLE STRENGTH; NEUROMUSCULAR DISEASE; PATIENT POSITIONING; PEAK EXPIRATORY FLOW; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; PROGNOSIS; PULSE OXIMETRY; REVIEW; SCREENING TEST; SLEEP APNEA SYNDROME; SOMNOLENCE; SPIROMETRY; TRANSCUTANEOUS OXYGEN MONITORING; VITAL CAPACITY;

EID: 33645778810     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(06)75034-2     Document Type: Review

References (55)

1. ABOUSSOUAN LS, KHAN SU, BANERJEE M, ARROLIGA AC, MITSUMOTO H. (2001). Objective measures of the efficacy of non invasive positive pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve, 24: 403-409.
2. ARNULF I, MEHIRI S, ATTALI V et al. (2000). Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. Am J Respir Crit Care Med, 161: 849-856.
3. AMERICAN THORACIC SOCIETY. (2004). Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med, 170: 456-465.
4. ATS/ERS. (2002). Statement on respiratory muscle testing. Am J Respir Crit Care Med, 166: 518-624.
5. BACH JR, ISHIKAWA Y, KIM H. (1997). Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest, 122: 1024-1028.
6. BLACK LF, HYATT RE. (1969). Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis, 99: 696-702.
7. BLACK LF, HYATT RE. (1971). Maximal static respiratory pressures in generalized neuromuscular disease. Am Rev Respir Dis, 103: 641-649.
8. BORG GAV. (1982). Psychophysical bases of perceived exertion. Med Sci Sports Exerc, 14: 377-381.
9. BOURKE SC, SHAW PJ, GIBSON GJ. (2001). Respiratory function vs sleep disordered breathing as predictors of QOL in ALS. Neurology, 57: 2040-2044.
10. BOURKE SC, GIBSON GJ. (2002). Sleep and breathing in neuromuscular disease. Eur Respir J, 19: 1194-1201.
11. BOURKE SC, BULLOCK RE, WILLIAMS TL, SHAW PJ, GIBSON GJ. (2003). Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology, 61: 171-177.
12. BOURKE SC, MC COLL E, SHAW PJ, GIBSON GJ. (2004). Validation of quality of life instruments in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord, 5: 55-60.
13. CEDARBAUM JM, STAMBLER N, MALTA E et al. (1999). The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci, 169: 13-21.
14. CHEN HI, TANG YR. (1989). Sleep loss impairs inspiratory muscle endurance. Am Rev Respir Med, 140: 907-909.
15. CONSENSUS CONFERENCE. (1999). Clinical indications for non invasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD and nocturnal hypoventilation- A consensus conference report. Chest, 116: 521-534.
16. CULEBRAS A. (1996). Sleep and neuromuscular disorders. Neurol Clinics, 14: 791-805.
17. FALLAT RJ, JEWITT B, BASS M. (1979). Spirometry in amyotrophic lateral sclerosis. Arch Neurol, 36: 74-80.
18. FARRERO E, PRATS E, PODEVANO M, MARTINEZ-MATOS JA, MANRESA F, ESCARRABIL J. (2005). Survival in amyotrophic lateral sclerosis with home mechanical ventilation: the impact of systematic respiratory assessment and bulbar involvement. Chest, 127: 2132-2138.
19. FERGUSON KA, STRONG MJ, AHMAD D, GEORGE CF. (1993). Sleep-disordered breathing in amyotrophic lateral sclerosis. Chest, 110: 664-669.
20. FITTING JW, PAILLEX R, HIRT L, AEBISCHER P, SCHLUEP M. (1999). Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol, 46: 887-893.
21. GAY P, WESTBROOK P, DAUBE J. (1991). Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis. Mayo Clin Proc, 66: 686-94.
22. HAHN A, BACH JR, RENARDEL-IRANI A, GUILLOU C, RIDEAU Y. (1997). Clinical implications of maximal respiratory pressure determination for individuals with Duchenne muscular dystrophy. Arch Phys med Rehab, 78: 1-6
23. HART N, POLKEY MI, SHARSHAR T et al. (2003). Limitations of sniff nasal pressure in patients with severe neuromuscular weakness. J Neurol Neurosurg Psychiatry, 74: 1685-1687.
24. HUKINS DA, HILLMAN DR. (2000). Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med, 161: 166-170.
25. KLEOPA KA, SHERMAN M, NEAL B, ROMANO GJ, HEIMAN-PATTERSON T. (1999). Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci, 15: 1-2
26. LACOMBLEZ L, BENSIMON G, LEIGH PN, GUILLET P, MEININGER V. (1996). For the ALS Riluzole Study Group II. Dose-ranging study of Riluzole in amyotrophic lateral sclerosis. Lancet 347: 1425-1431.
27. LAGHI F, TOBIN MJ. (2003). Disorders of the respiratory muscles. Am J Respir Crit Care Med, 168: 10-48.
28. LECHTZIN N, WIENER CM, SHADE DM, CLAWSON L, DIETTE GB. (2002). Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest, 121: 435-442.
29. LEVY P, PÉPIN JL, DESCHAUX-BLANC C, PARAMELLE B, BRAMBILLA C. (1996). Accuracy of oxymetry for detection of respiratory disturbance in sleep apnea syndrome. Chest, 109: 395-399.
30. LYALL RA, DONALDSON N, LEIGH N, MOXHAM J. (2001). Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain, 124: 2000-2013.
31. MAITRE B, SIMILOWSKI T, DERENNE JP. (1995). Physical examination of the adult patient with respiratory diseases: inspection and palpation. Eur Respir J, 8: 1584-1593.
32. MEININGER V, BENSIMON G, BRADLEY WR et al. (2004). Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials. Amyotroph Lateral Scler Other Motor Neuron Disord, 5: 107-117.
33. MIER-JEDRZEJOWICZ A, BROPHY C, MOXHAM J, GREEN M. (1988). Assessment of diaphragm weakness. Am Rev Respir Dis, 137: 877-883.
34. MILLER RG, ROSENBERG JA, GELINAS DF et al. (1999). Oppenheimer EA and the ALS Practice Parameters Task Force. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology, 52: 1311-1323.
35. MORGAN RK, MCNALLY S, ALEXANDER M, CONROY R, HARDIMAN O, COSTELLO RW. (2005). Use of sniff nasal inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med, 171: 269-274.
36. NEWSOM-DAVIS IC, LYALL RA, LEIGH PN, GOLDSTEIN RH. (2001). The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis: a prospective study. J Neurol Neurosurg, 71: 482-487.
37. PEPIN JL, CHOURI-PONTAROLLO N, ORLIAGUET O, LEVY P. (2005). Alveolar hypoventilation during sleep and domiciliary assisted ventilation. Rev Mal Respir, 22: 113-125.
38. PEREZ T. (2005). Exploration de première intention des muscles respiratoires. Rev Mal Respir, 2 : 2S37-2S46.
39. PERRIN C, UNTERBORN JN, D'AMBROSIO C, HILL NS. (2004). Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve, 29: 5-27.
40. PINTO AC, DE CARVALAO M, EVANGELISTA T, LOPES A, SALES-LUIS L. (2003). Nocturnal pulse oxymetry: a new approach to establish the appropriate time for non-invasive ventilation in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord, 4: 31-35.
41. POLKEY MI, GREEN M, MOXHAM J. (1995). Measurement of respiratory muscle strength. Thorax, 50: 1131-1135.
42. POLKEY MI, LYALL RA, GREEN M, LEIGH PN, MOXHMA J. (1998). Expiratory muscle function in amyotrophic lateral sclerosis. Am J Respir Crit Care Med, 158: 734-741.
43. POLKEY MI, LYALL RA, MOXHAM J, LEIGH PN. (1999). Respiratory aspects of neurological disease. J Neurol Neurosurg Psychiatry, 66: 5-15.
44. RAGETTE R, MELLIES U, SCWAKE C, VOIT T, TESCHLER H. (2002). Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax, 57: 724-728.
45. RAPHAEL JC, CHEVRET S, CHASTANG C, BOUVET F. (1994). Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. French Multicentre Cooperative Group on Home Mechanical Ventilation Assistance in Duchenne de Boulogne Muscular Dystrophy. Lancet, 343: 1600-1604.
46. SCHIFFMAN PL, BELSH JM. (1993). Pulmonary function at diagnosis of amyotrophic lateral sclerosis: rate of deterioration. Chest, 103: 508-513.
47. SCHLOSSHAN D, ELLIOTT MW. (2004). Clinical presentation and diagnosis of the obstructive sleep apnoea hypopnoea syndrome. Thorax, 59: 347-352.
48. SIMILOWSKI T, ATTALI V, BENSIMON G et al. (2000). Diaphragmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis. Eur Respir J, 15: 332-337.
49. STAMBLER N, CHARATAN M, CEDARBAUM JM. (1998). Pronostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology, 50: 66-72.
50. STEFANUTTI D, BENOIST MR, SCHEINMANN P, CHAUSSAIN M, FITTING JW. (2000). Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med, 162: 1507-1511.
51. SZEINBERG A, TABACHNIK E, RASHED N et al. (1988). Cough capacity in patients with muscular dystrophy. Chest, 94: 1232-1235.
52. TZENG AC AND BACH JR. (2000). Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest, 118: 1390-1396.
53. ULDRY C, FITTING JW. (1995). Maximal values of sniff nasal inspiratory pressure in healthy subjects. Thorax, 50: 371-375.
54. VARRATO J, SIDEROWF A, DAMIANO P, GREGORY S, FEINBERG D, MCCLUSKEY L. (2001). Postural change of forced vital capacity predicts some respiratory symptoms in ALS. Neurology, 57: 357-359.
55. VITTACA M, CLINI E, FACCHETTI D et al. (1997). Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis. Eur Resp J, 10: 1614-1621.